Mydecine Innovations Group Stock Market Value
| MYCOF Stock | USD 0 0 28.00% |
| Symbol | Mydecine |
Mydecine Innovations 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mydecine Innovations' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mydecine Innovations.
| 12/08/2022 |
| 11/27/2024 |
If you would invest 0.00 in Mydecine Innovations on December 8, 2022 and sell it all today you would earn a total of 0.00 from holding Mydecine Innovations Group or generate 0.0% return on investment in Mydecine Innovations over 720 days. Mydecine Innovations is related to or competes with Genomma Lab. Mydecine Innovations Group Inc., a biotech and life sciences company, engages in the development and commercialization o... More
Mydecine Innovations Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mydecine Innovations' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mydecine Innovations Group upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 38.95 | |||
| Information Ratio | 0.1542 | |||
| Maximum Drawdown | 198.41 | |||
| Value At Risk | (50.00) | |||
| Potential Upside | 100.0 |
Mydecine Innovations Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mydecine Innovations' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mydecine Innovations' standard deviation. In reality, there are many statistical measures that can use Mydecine Innovations historical prices to predict the future Mydecine Innovations' volatility.| Risk Adjusted Performance | 0.1301 | |||
| Jensen Alpha | 7.53 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.1684 | |||
| Treynor Ratio | (0.95) |
Mydecine Innovations Backtested Returns
Mydecine Innovations is out of control given 3 months investment horizon. Mydecine Innovations has Sharpe Ratio of 0.14, which conveys that the firm had a 0.14% return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 6.15% are justified by taking the suggested risk. Use Mydecine Innovations Mean Deviation of 30.27, downside deviation of 38.95, and Risk Adjusted Performance of 0.1301 to evaluate company specific risk that cannot be diversified away. Mydecine Innovations holds a performance score of 11 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -7.05, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Mydecine Innovations are expected to decrease by larger amounts. On the other hand, during market turmoil, Mydecine Innovations is expected to outperform it. Use Mydecine Innovations information ratio, downside variance, day typical price, as well as the relationship between the treynor ratio and kurtosis , to analyze future returns on Mydecine Innovations.
Auto-correlation | 0.43 |
Average predictability
Mydecine Innovations Group has average predictability. Overlapping area represents the amount of predictability between Mydecine Innovations time series from 8th of December 2022 to 3rd of December 2023 and 3rd of December 2023 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mydecine Innovations price movement. The serial correlation of 0.43 indicates that just about 43.0% of current Mydecine Innovations price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.43 | |
| Spearman Rank Test | 0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Mydecine Innovations lagged returns against current returns
Autocorrelation, which is Mydecine Innovations pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mydecine Innovations' pink sheet expected returns. We can calculate the autocorrelation of Mydecine Innovations returns to help us make a trade decision. For example, suppose you find that Mydecine Innovations has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Mydecine Innovations regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mydecine Innovations pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mydecine Innovations pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mydecine Innovations pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Mydecine Innovations Lagged Returns
When evaluating Mydecine Innovations' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mydecine Innovations pink sheet have on its future price. Mydecine Innovations autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mydecine Innovations autocorrelation shows the relationship between Mydecine Innovations pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Mydecine Innovations Group.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Mydecine Pink Sheet
Mydecine Innovations financial ratios help investors to determine whether Mydecine Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mydecine with respect to the benefits of owning Mydecine Innovations security.